Objectives: Ketamine is a glutamate N-methyl-D-aspartate receptor antagonist that can be
used to treat major depressive disorder by single or repeated infusions. However, the …

Basic pain research has shed light on key cellular and molecular mechanisms underlying
nociceptive and phenomenological aspects of pain. Despite these advances, we still yearn …

Background Psilocybin therapy is receiving attention as a mental health intervention with
transdiagnostic potential. In line with psychotherapeutic research, qualitative research has …

Acute injections of ketamine lead to rapid but transient antidepressant effects. Chronic oral
treatment at low doses, a promising non-invasive alternative, may prolong this therapeutic …

In-house digital fabrication of low-cost sensors that can on-site and rapidly detect
adulteration of alcoholic beverages with sedation drugs (known as date rape drugs,(DRDs)) …

The so-called “psychedelic renaissance” has stimulated expanded interest in several
classes of drugs that appear to possess transdiagnostic effects in the treatment of mental …

Major depressive disorder is a highly prevalent psychiatric disorder. Despite an extensive
range of treatment options, about a third of patients still struggle to respond to available …

Ketamine is a promising alternative to traditional pharmacotherapies for major depressive
disorder, treatment-resistant depression, and other psychiatric conditions that heavily …

Ketamine has received considerable attention for its rapid and robust antidepressant
response over the past decade. Current evidence, in clinical populations, predominantly …

Background Limited published data exists that collates serious adverse outcomes involving
ketamine as a psychiatric intervention. This systematic review assesses the reported …